Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Long-standing intestinal inflammation in patients with inflammatory bowel disease (IBD) induces dysplastic change in the intestinal mucosa and increases the risk of subsequent colorectal cancer. The evolving endoscopic techniques and technologies, including dye spraying methods and high-definition images, have been replacing random biopsies and have been revealed as more practical and efficient for detection of dysplasia in IBD patients. In addition, they have potential usefulness in detailed characterization of lesions and in the assessment of endoscopic resectability. Most dysplastic lesions without an unclear margin, definite ulceration, non-lifting sign, and high index of malignant change with suspicion for lymph node or distant metastases can be removed endoscopically. However, endoscopic resection of dysplasia in chronic IBD patients is usually difficult because it is often complicated by submucosal fibrosis. In patients with dysplasias that demonstrate submucosa fibrosis or a large size (≥20 mm), endoscopic submucosal dissection (ESD) or ESD with snaring (simplified or hybrid ESD) is an alternative option and may avoid a colectomy. However, a standardized endoscopic therapeutic approach for dysplasia in IBD has not been established yet, and dedicated specialized endoscopists with interest in IBD are needed to fully investigate recent emerging techniques and technologies.
Abstract
Long-standing intestinal inflammation in patients with inflammatory bowel disease (IBD) induces dysplastic change in the intestinal mucosa and increases the risk of subsequent colorectal cancer. The evolving endoscopic techniques and technologies, including dye spraying methods and high-definition images, have been replacing random biopsies and have been revealed as more practical and efficient for detection of dysplasia in IBD patients. In addition, they have potential usefulness in detailed characterization of lesions and in the assessment of endoscopic resectability. Most dysplastic lesions without an unclear margin, definite ulceration, non-lifting sign, and high index of malignant change with suspicion for lymph node or distant metastases can be removed endoscopically. However, endoscopic resection of dysplasia in chronic IBD patients is usually difficult because it is often complicated by submucosal fibrosis. In patients with dysplasias that demonstrate submucosa fibrosis or a large size (≥20 mm), endoscopic submucosal dissection (ESD) or ESD with snaring (simplified or hybrid ESD) is an alternative option and may avoid a colectomy. However, a standardized endoscopic therapeutic approach for dysplasia in IBD has not been established yet, and dedicated specialized endoscopists with interest in IBD are needed to fully investigate recent emerging techniques and technologies.
참고문헌 (48)
- Ekbom A, "Ulcerative colitis and colorectal cancer. A population-based study", N Engl J Med, 323, pp.1228~1233 (1990)
- Ekbom A, "Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement", Lancet, 336, pp.357~359 (1990)
- Söderlund S, "Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease", Gastroenterology, 136, pp.1561~1567 (2009)
- Bernstein CN, "Cancer risk in patients with inflammatory bowel disease: a population-based study", Cancer, 91, pp.854~862 (2001)
- Jess T, "Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years", Gastroenterology, 143, pp.375~381 (2012)
- Jess T, "Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies", Clin Gastroenterol Hepatol, 10, pp.639~645 (2012)
- Devroede G, "On calculating cancer risk and survival of ulcerative colitis patients with the life table method", Gastroenterology, 71, pp.505~509 (1976)
- Matkowskyj KA, "Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology", Arch Pathol Lab Med, 137, pp.338~350 (2013)
- Lutgens MW, "Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies", Inflamm Bowel Dis, 19, pp.789~799 (2013)
- Magro F, "Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1:definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders", J Crohns Colitis, 11, pp.649~670 (2017)
- Farraye FA, "AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease", Gastroenterology, 138, pp.738~745 (2010)
- Rutter MD, "Most dysplasia in ulcerative colitis is visible at colonoscopy", Gastrointest Endosc, 60, pp.334~339 (2004)
- Laine L, "SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease", Gastroenterology, 148, pp.639~651 (2015)
- Leedham SJ, "Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia", Gastroenterology, 136, pp.542~550 (2009)
- Issa JP, "Accelerated age-related CpG island methylation in ulcerative colitis", Cancer Res, 61, pp.3573~3577 (2001)
- Lyda MH, "Multifocal neoplasia involving the colon and appendix in ulcerative colitis:pathological and molecular features", Gastroenterology, 115, pp.1566~1573 (1998)
- Graham TA, "Field cancerization in the GI tract", Future Oncol, 7, pp.981~993 (2011)
- Marcellin P, "Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study", Lancet, 381, pp.468~475 (2013)
- Blackstone MO, "Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy", Gastroenterology, 80, pp.366~374 (1981)
- ASGE Technology Committee, "High-definition and high-magnification endoscopes", Gastrointest Endosc, 80, pp.919~927 (2014)
- Odze R, "Diagnostic problems and advances in inflammatory bowel disease", Mod Pathol, 16, pp.347~358 (2003)
- Soetikno R, "Paradigm shift in the surveillance and management of dysplasia in inflammatory bowel disease (West)", Dig Endosc, 28, pp.266~273 (2016)
- Imai K, "Should laterally spreading tumors granular type be resected en bloc in endoscopic resections?", Surg Endosc, 28, pp.2167~2173 (2014)
- Kudo S, "Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer", World J Surg, 24, pp.1081~1090 (2000)
- Hayashi N, "Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification", Gastrointest Endosc, 78, pp.625~632 (2013)
- Ikematsu H, "Efficacy of capillary pattern type IIIA", IIIB by magnifying narrow band imaging for estimating depth of invasion of early colorectal neoplasms, 2010, pp.10, 33~
- Shergill AK, "The role of endoscopy in inflammatory bowel disease", Gastrointest Endosc, 81, pp.1101~1121 (2015)
- Rubin DT, "Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?", Gastrointest Endosc, 65, pp.998~1004 (2007)
- Mowat C, "Guidelines for the management of inflammatory bowel disease in adults", Gut, 60, pp.571~607 (2011)
- Uraoka T, "Colorectal endoscopic submucosal dissection: is it suitable in western countries?", J Gastroenterol Hepatol, 28, pp.406~414 (2013)
- Repici A, "Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review", Endoscopy, 44, pp.137~150 (2012)
- Kuroki Y, "Endoscopic submucosal dissection for residual", locally recurrent lesions after endoscopic therapy for colorectal tumors, 2010, pp.25, 1747~1753
- Wanders LK, "Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis", Clin Gastroenterol Hepatol, 12, pp.756~764 (2014)
- Iacucci M, "Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease", Can J Gastroenterol Hepatol, 28, pp.361~370 (2014)
- Smith LA, "Endoscopic resection of adenoma-like mass in chronic ulcerative colitis using a combined endoscopic mucosal resection and cap assisted submucosal dissection technique", Inflamm Bowel Dis, 14, pp.1380~1386 (2008)
- Leighton JA, "ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease", Gastrointest Endosc, 63, pp.558~565 (2006)
- Kornbluth A, "Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee", Am J Gastroenterol, 105, pp.501~523 (2010)
- Jess T, "Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota", Inflamm Bowel Dis, 12, pp.669~676 (2006)
- Rubin PH, "Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps", Gastroenterology, 117, pp.1295~1300 (1999)
- Blonski W, "High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis", Scand J Gastroenterol, 43, pp.817~820 (2008)
- Goldstone R, "Progression of lowgrade dysplasia in ulcerative colitis: effect of colonic location", Gastrointest Endosc, 74, pp.1087~1093 (2011)
- Kisiel JB, "Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy", Inflamm Bowel Dis, 18, pp.226~235 (2012)
- Medlicott SA, "Conservative management of small adenomata in ulcerative colitis", Am J Gastroenterol, 92, pp.2094~2098 (1997)
- Odze RD, "Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis", Clin Gastroenterol Hepatol, 2, pp.534~541 (2004)
- Pekow JR, "Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis", Inflamm Bowel Dis, 16, pp.1352~1356 (2010)
- Rozen P, "Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis", Gastroenterology, 108, pp.1361~1370 (1995)
- Vieth M, "Sporadic adenoma in ulcerative colitis:endoscopic resection is an adequate treatment", Gut, 55, pp.1151~1155 (2006)
- Harbord M, "Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management", J Crohns Colitis, 11, pp.769~784 (2017)